Showing results 11 to 17 of 17
< previous
Issue Date | Title | Author(s) |
6-Sep-2016 | Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer | Dalgleish, AG; Stebbing, J; Adamson, DJA; Arif, SS; Bidoli, P, et al |
Feb-2021 | SCIRT lncRNA restrains tumorigenesis by opposing transcriptional programs of tumor-initiating cells. | Zagorac, S; De Giorgio, A; Dabrowska, A; Kalisz, M; Casas-Vila, N, et al |
15-Jun-2019 | SSB1/SSB2 proteins safeguard B-cell development by protecting the genomes of B-cell precursors | Pfeifer, M; Brem, R; Lippert, T; Boulianne, B; Ho, HN, et al |
25-Jan-2017 | Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR | Castellano, L; Dabrowska, A; Pellegrino, L; Ottaviani, S; Cathcart, P, et al |
10-May-2018 | TGF-ß induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression | Ottaviani, S; Stebbing, J; Frampton, A; Zagorac, S; Krell, J, et al |
16-Jan-2018 | The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas | Carter, P; Alifrangis, CC; Chandrasinghe, P; Cereser, B; Del Bel Belluz, L, et al |
17-Jan-2012 | The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy | Payne, RE; Hava, NL; Page, K; Blighe, K; Ward, B, et al |